Mitosis identification in diffuse gliomas: Implications for tumor grading

Cancer

Volumn 82, Issue 8, 1998, Pages 1550-1555

  Coons, Stephen W ^a   Pearl, Dennis K ^b  

^a BARROW NEUROLOGICAL INSTITUTE   (United States)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

Glioma; Histologic grade; Mitoses; Survival

Indexed keywords

ARTICLE; ASTROCYTOMA; CANCER GRADING; CANCER SURVIVAL; CONTROLLED STUDY; CORRELATION FUNCTION; GLIOMA; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MITOSIS; OLIGODENDROGLIOMA; PRIORITY JOURNAL;

BIOPSY; BRAIN NEOPLASMS; FOLLOW-UP STUDIES; GLIOMA; HUMANS; MITOSIS; OLIGODENDROGLIOMA; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 0032522971     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19980415)82:8<1550::AID-CNCR17>3.0.CO;2-3     Document Type: Article

References (33)

1. Ringertz N. "Grading" of gliomas. Acta Pathol Microbiol Scand 1950;27:51-64.
2. Burger PC, Vogel FS, Green SB, Strike TA. Glioblastoma multiforme and anaplastic astrocytoma: pathologic criteria and prognostic implications. Cancer 1985;56:1106-11.
3. Daumas-Duport C, Scheithauer B, O'Fallon J, Kelly P. Grading of astrocytomas: a simple and reproducible method. Cancer 1988;62:2152-65.
4. Kleihues P. WHO histological typing of tumours of the central nervous system. Berlin: Springer-Verlag, 1993.
5. Shaw EG, Scheithauer BW, O'Fallon JR, Tazelaar HD, Davis DH. Oligodendrogliomas: the Mayo Clinic experience. J Neurosurg 1992;76:428-34.
6. Shaw EG, Scheithauer BW, O'Fallon JR, Davis DH. Mixed oligoastrocytomas: a survival and prognostic factor analysis. Neurosurgery 1994;34:577-82.
7. Coons SW, Johnson PC, Pearl DK, Olafsen AG. Prognostic significance of flow cytometry deoxyribonucleic acid analysis of human oligodendrogliomas. Neurosurgery 1994;34:680-7.
8. Coons SW, Johnson PC, Pearl DK. The prognostic significance of Ki-67 labeling indices for oligodendrogliomas. Neurosurgery. 1997;40:878-85.
9. Heegaard S, Sommer HM, Broholm H, Broendstrup O. Proliferating cell nuclear antigen and Ki-67 immunohistochemistry of oligodendrogliomas with special reference to prognosis. Cancer 1995;76:1809-13.
10. Kros JM, Hop WCJ, Godschalk JJCJ, Krishnadath KK. Prognostic value of the proliferation-related antigen Ki-67 in oligodendrogliomas. Cancer 1996;78:1107-13.
11. Kernohan JW, Mabon RF, Svien HJ, Adson AW. A simplified classification of the gliomas. Mayo Clin Proc 1949;24:71-4.
12. Earnest F III, Kernohan JW, Craig WM. Oligodendrogliomas: a review of two hundred cases. Arch Neurol Psychiatry 1950;63:964-76.
13. Weidner N, Moore DH II, Vartanian R. Correlation of Ki-67 antigen expression with mitotic figure index and tumor grade in breast carcinomas using the novel "paraffin"-reactive MIB1 antibody. Hum Pathol 1994;25:337-42.
14. Going JJ. Efficiently estimated histologic cell counts. Hum Pathol 1994;25:333-6.
15. van Diest PJ, Baak JP, Matze-Cok P, Wisse-Brekelmans ECM, van Galen CM, Kurver PHJ, et al. Reproducibility of mitosis counting in 2,469 breast cancer specimens: results from the Multicenter Morphometric Mammary Carcinoma Project. Hum Pathol 1992;23:603-7.
16. Coons SW, Johnson PC, Pearl DK. Prognostic significance of flow cytometry deoxyribonucleic acid analysis of human astrocytomas. Neurosurgery 1994;35:119-26.
17. Hoshino T, Ahn D, Prados MD, Lamborn K, Wilson CB. Prognostic significance of the proliferative potential of intracranial gliomas measured by bromodeoxyuridine labeling. Int J Cancer 1993;53:550-5.
18. Sallinen PK, Haapasalo HK, Visakorpi T, Helen PT, Rantala IS, Isola JJ, et al. Prognostication of astrocytoma patient survival by Ki-67 (MIB-1), PCNA, and S-phase fraction using archival paraffin-embedded samples. J Pathol 1994; 174:275-82.
19. Montine TJ, Vandersteenhoven JJ, Aguzzi A, Boyko OB, Dodge RK, Kerns B-J, et al. Prognostic significance of Ki-67 proliferation index in supratentorial fibrillary astrocytic neoplasms. Neurosurgery 1994;34:674-8.
20. Ellison DW, Steart PV, Bateman AC, Pickering RM, Palmer JD, Weller RO. Prognostic indicators in a range of astrocytic tumours: an immunohistochemical study with Ki-67 and p53 antibodies. J Neurol Neurosurg Psychiatry 1995;59:413-9.
21. Wakimoto H, Aoyagi M, Nakayama T, et al. Prognostic significance of Ki-67 labeling indices obtained using MIB-1 monoclonal antibody in patients with supratentorial astrocytomas. Cancer 1996;77:373-80.
22. Burger PC, Rawlings CE, Cox EB, McLendon RE, Schold SC Jr., Bullard DE. Clinicopathologic correlations in the oligodendroglioma. Cancer 1987;59:1345-52.
23. Burger PC, Scheithauer BW, Vogel FS. Surgical pathology of the nervous system and its coverings. New York: Churchill Livingstone, 1991:193-437.
24. Smith MT, Ludwig CL, Godfrey AD, Armbrustmacher VW. Grading of oligodendrogliomas. Cancer 1983;52:2107-14.
25. Mork SJ, Halversen TB, Lindegaard K-F, Eide GE. Oligodendroglioma: histologic evaluation and prognosis. J Neuropathol Exp Neurol 1986;45:65-78.
26. Bruner JM. Oligodendroglioma: diagnosis and prognosis. Semin Diagn Pathol 1987;4:251-61.
27. Paulus W, Peiffer J. Intratumoral histologic heterogeneity of gliomas: a quantitative study. Cancer 1989;64:442-7.
28. Glantz MJ, Burger PC, Herndon JE II, Friedman AH, Cairncross JC, Vick NA, et al. Influence of the type of surgery on the histologic diagnosis in patients with anaplastic gliomas. Neurology 1991;41:1741-4.
29. Daumas-Duport C, Monsaingeon V, N'Guyen JP, Missir O, Szikla G. Some correlations between histological and CT aspects of cerebral gliomas contributing to the choice of significant trajectories for stereotactic biopsies. Acta Neurochir Suppl (Wien) 1984;33:185-94.
30. Kepes JJ. Pitfalls and problems in the histopathologic evaluation of stereotactic needle biopsy specimens. Neurosurg Clin N Am 1994;5:19-33.
31. Taratuto AL, Sevlever G, Piccardo P. Clues and pitfalls in stereotactic biopsy of the central nervous system. Arch Pathol Lab Med 1991;115:596-602.
32. Coons SW, Johnson PC. Regional heterogeneity in the DNA content of human gliomas. Cancer 1993;72:3052-60.
33. Coons SW, Johnson PC. Regional heterogeneity in the proliferative activity of human gliomas as measured by the Ki-67 labeling index. J Neuropathol Exp Neurol 1993; 52:609-18.